* The Tetraflex HD is currently pending FDA approval and is not yet available in the US.
Lenstec's Tetraflex is an accomodating intraocular lens implant (IOL) that is used for cataract surgery. The Tetraflex IOL not only replaces the cloudy cataractous lens with a clear lens, it also accomodates to give a range of vision. The Tetraflex is not yet FDA approved in the United States, but is currently in use in Europe. It is expected that Lenstec will also introduce Tetraflex HD after FDA approval. Lenstec's Softec HD is a precision monofocal lens that is already FDA approved for single focus lens replacement. The expected advantage of the Tetraflex and Tetraflex HD over the Softec HD is a wider range of sharp vision without glasses or contact lenses for distance, computer, and reading activities. The lens works by flexing within the eye when patients attempt to read.
Tetraflex reviews have been favorable by surgeons and patients. Below is a TV news story about patient who had Tetraflex IOL in Miami during U.S. FDA trials.
The Tetraflex costs may be partially covered under medical insurance, but normally there are added out-of-pocket Tetraflex costs compared to lenses that do not accomodate. Dr. Zudans will offer the Tetraflex IOL once it receives FDA approval in the U.S.